- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Merck's (MRK) Keytruda treatment improved the survival rate of patients with bladder cancer who previously underwent treatment.
Look for solid companies showing life.
Here are Thursday's top research calls, including upgrades for Anadarko Petroleum, GrubHub and Merck, and a downgrade for Pfizer.